Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive
Nopparat Srakaew(Ottawa Hospital), Nongnuj Tanphaichitr(University of Ottawa), Louis Hermo(McGill University), C. D. Young(Ottawa Hospital), Krista Quesnel(University of Ottawa), Kessiri Kongmanas(Siriraj Hospital), Y.-L. Zhang(Chinese Academy of Sciences), Luigi Panza(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Arpornrad Saewu(Ottawa Hospital), Federica Compostella(University of Milan), Duriya Fongmoon(Ottawa Hospital), Robert E. W. Hancock(University of British Columbia), Hongbin Xu(University of Ottawa), Richard Oko(Queen's University), Greanggrai Hommalai(Ottawa Hospital), Wattana Weerachatyanukul(Mahidol University), Terry W. Pearson(University of Victoria), Susan H. Hall(University of North Carolina at Chapel Hill), L. Franchini(University of Milan), Riccardo di Brisco(Ottawa Hospital)
Cited by 38
Related Papers
Cationic peptides: a new source of antibiotics
|Trends in biotechnology|1998|1.3k
Endocrine Regulation of Male Fertility by the Skeleton
|Cell|2011|617
Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index
|Journal of Biological Chemistry|2005|598
Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37
|The Journal of Immunology|2006|556